Thursday May 25th 2017

Archive for August, 2012

Sask. man with MS undergoing one of two procedures as part of study

Sask. man with MS undergoing one of two procedures as part of study

News Talk Radio first told you about Andrew Dahlen, a 28-year-old Saskatoon man with Multiple Sclerosis, who was hoping to undergo the controversial liberation treatment as part of a study involving clinical trials by the provincial government. Today, Dahlen is in Albany, [Read More]

New study challenges controversial multiple sclerosis treatment

New study challenges controversial multiple sclerosis treatment

A study published Tuesday is providing further confirmation that a controversial theory arguing multiple sclerosis is caused by neck vein abnormalities is not credible. The findings have prompted a prominent multiple sclerosis expert in the U.S. to criticize the Canadian [Read More]

Creekers plan benefit for musician

Creekers plan benefit for musician

Bragg Creekers are banding together, with the well-being of Calgary musician, Aaron (Shea) Bonney in mind. Tonight (Aug. 15) beginning at 6 p.m., the Bragg Creek Steak Pit will host a jam-slash-fundraiser in support of the 34 year old, whose 12-year-battle with multiple [Read More]

 Page 1 of 2  1  2 »

Latest Topics

Study finds variations among hospitals in transitioning stroke patients from treatment to comfort care

Study finds variations among hospitals in transitioning stroke patients from treatment to comfort care

Hospitals vary widely in how often they transition people with strokes from active treatment to comfort or hospice care [Read More]

Roche investigating case of patient illness after taking MS drug

Roche investigating case of patient illness after taking MS drug

ZURICH (Reuters) - A person in Germany treated with Roche ’s new multiple sclerosis drug Ocrevus has been diagnosed [Read More]

MS Study Alert: Share Your Thoughts About MS Research

MS Study Alert: Share Your Thoughts About MS Research

/About-the-Society/News/MS-Study-Alert-Share-Your-Thoughts-About-MS-Resea [Read More]

Mallinckrodt begins enrolment in Phase IV trial of HP Acthar gel for RRMS

Mallinckrodt begins enrolment in Phase IV trial of HP Acthar gel for RRMS

UK-based specialist pharmaceutical firm Mallinckrodt has begun patient enrolment in the Phase IV OPTIONS clinical trial [Read More]

First Results Announced from Second Phase III Trial of Oral Ozanimod in People with Relapsing MS

First Results Announced from Second Phase III Trial of Oral Ozanimod in People with Relapsing MS

/About-the-Society/News/First-Results-Announced-from-Second-Phase-III-Tria [Read More]